SINCE Maiman
1 first developed a ruby laser, laser design has advanced to the point that lasers are now used to treat many vitreoretinal conditions.
2 Argon, krypton, and, more recently, diode lasers have been shown to produce therapeutically useful lesions that have a similar ophthalmoscopic appearance, and that also appear on histological examination of both human and animal eyes to elicit similar tissue effects on the outer retina and retinal pigment epithelium (RPE).
3-8 The extent of tissue damage that is required to generate a therapeutic outcome is generally not known. Gray-white burns are used because they can be detected clinically at the time of treatment, and ancillary damage to the retina has been considered acceptable or perhaps unavoidable.